Article Versions Notes

Fang W, Chen Y, Nie M, Zhou X, Liu Y, Tao H, Yang B, Wang X. Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation. Marine Drugs. 2025; 23(5):214. https://doi.org/10.3390/md23050214

Fang, Wenxuan, Ying Chen, Mingyi Nie, Xuefeng Zhou, Yonghong Liu, Huaming Tao, Bin Yang, and Xueni Wang. 2025. "Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation" Marine Drugs 23, no. 5: 214. https://doi.org/10.3390/md23050214

Fang, W., Chen, Y., Nie, M., Zhou, X., Liu, Y., Tao, H., Yang, B., & Wang, X. (2025). Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation. Marine Drugs, 23(5), 214. https://doi.org/10.3390/md23050214